Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supported Employment With Behavioral Skills Training in Schizophrenia
NCT00183625Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2000
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of risperidone and olanzapine in schizophrenia (4 arms), sponsored by University of California, Los Angeles. Primary endpoint: Total Weeks Worked at 24 months. Started Jun 2000; status: completed.
02
Drugs
risperidoneolanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00183625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183625.